Jens Ulrik Holst
Geen lopende functies
Loopbaan van Jens Ulrik Holst
Eerdere bekende functies van Jens Ulrik Holst
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Arlington Capital Investors Ltd.
 Arlington Capital Investors Ltd. Financial ConglomeratesFinance Arlington Capital Investors Ltd. (Arlington) is the investment management subsidiary of Arlington Capital Management (CI) Ltd. (Guernsey). The firm was founded in 1991 and is based in London. In addition to investing in a limited number of quoted companies around the themes of industrial reform, corporate restructuring and shareholder value, Arlington manages the European Renaissance Fund. | Lid van de Investeringscommissie | 01-09-2003 | 01-02-2010 |
| Verkoop & Marketing | 01-09-2003 | 01-02-2010 | |
Origio A/S
 Origio A/S BiotechnologyHealth Technology ORIGIO A/S manufactures and markets assisted reproduction technologies and related human reproductive products. Its products include Andrology, sequential series, EmbryoGem, BlastGen, Pipettes, ICSI micropipets. The company was founded in 1987 and is headquartered in Maaloev, Denmark. | Voorzitter | 31-03-2010 | 31-03-2010 |
Opleiding van Jens Ulrik Holst
| University of Mannheim | Masters Business Admin |
Statistieken
Internationaal
| Verenigd Koninkrijk | 2 |
| Duitsland | 2 |
| Denemarken | 2 |
Operationeel
| Investment Committee Member | 1 |
| Sales & Marketing | 1 |
| Masters Business Admin | 1 |
Sectoraal
| Finance | 2 |
| Consumer Services | 2 |
| Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Arlington Capital Investors Ltd.
Arlington Capital Investors Ltd. Financial ConglomeratesFinance Arlington Capital Investors Ltd. (Arlington) is the investment management subsidiary of Arlington Capital Management (CI) Ltd. (Guernsey). The firm was founded in 1991 and is based in London. In addition to investing in a limited number of quoted companies around the themes of industrial reform, corporate restructuring and shareholder value, Arlington manages the European Renaissance Fund. | Finance |
Origio A/S
Origio A/S BiotechnologyHealth Technology ORIGIO A/S manufactures and markets assisted reproduction technologies and related human reproductive products. Its products include Andrology, sequential series, EmbryoGem, BlastGen, Pipettes, ICSI micropipets. The company was founded in 1987 and is headquartered in Maaloev, Denmark. | Health Technology |
- Beurs
- Insiders
- Jens Ulrik Holst
- Ervaring
